Bellerophone Therapeutics announced positive top-line data from a recently completed acute, intra-patient, dose escalation, hemodynamics study (PHPF-002) of INOpulse for the treatment of Pulmonary Hypertension associated with Pulmonary Fibrosis (PH-PF). The top-line...